Letby hospital forced whistleblower out of her job, tribunal rules
A former NHS boss and 'whistleblower' at the hospital where Lucy Letby murdered seven babies was bullied out of her job, an employment tribunal has found.
Dr Susan Gilby became chief executive at the Countess of Chester Hospital in September 2018, two months after Letby was first arrested, the Liverpool tribunal was told.
Dr Gilby, a consultant anaesthetist, told the tribunal that despite navigating the Covid-19 pandemic and improving the running of the hospital, she encountered difficulties when Ian Haythornthwaite, a former BBC accountant, became chairman of its board in 2021.
She claimed she was 'harassed and intimidated' by Mr Haythornthwaite, whom she accused of putting the financial security of the hospital before patient care.
She later 'blew the whistle' about her concerns about him and was suspended before she eventually resigned from her job in 2022.
Now her claim of unfair dismissal has been upheld. Judge Dawn Shotter, who chaired the tribunal, ruled that Mr Haythornthwaite and three other senior figures at the hospital worked together to remove Dr Gilby from her post.
Dr Gilby is expected to be awarded more than £1 million in compensation.
She told the hearing that in 2022 Mr Haythornthwaite launched a 'fierce verbal attack' upon her during which he 'banged his hand on the table' to emphasise things he claimed were 'wrong' with her, according to Mail Online.
She said his alleged behaviour was 'bullying, pure and simple', adding that the board was obsessed with imposing cuts at the hospital which, she felt, compromised patient safety.
At one point, she said, after she returned to work after a period of being signed off with stress, a non-executive director told her it was 'time to go'.
By then, the Letby trial at Manchester Crown Court had begun and she felt it was an inappropriate time to leave. She was formally suspended in December that year.
Dr Gilby said: 'I believe that I was pushed out of a role that I wanted to dedicate the last years of a 30-year unblemished healthcare record to because I had blown the whistle on the controlling and bullying behaviour of the leader of a group of finance specialists, many of whom are still in post at the Countess, and were hell bent on putting finances over patient care.'
Speaking after the tribunal verdict, Dr Gilby said the last few years had been 'nothing short of torture at times', adding: 'My career has been taken from me with no justification and the financial losses we have suffered are significant.'
She added that she had put her 'faith in the judicial system' after refusing to compromise her integrity.
Mr Haythornthwaite, 65, said: 'I have made the decision to step down with immediate effect from my role as chair of the trust.'
A spokesman for the Countess of Chester Hospital NHS Foundation Trust said it acknowledged the outcome of the tribunal and would review the judge's findings.
Letby, 35, was convicted of the murder of seven babies and attempting to murder seven more in the hospital's neo-natal unit between 2015 and 2016.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
33 minutes ago
- BBC News
Canterbury GP's genital exams 'unnecessary', court hears
A former GP conducted "unnecessary" genital examinations on nine male patients, including young teenagers, a court has Manson, 56, is alleged to have carried out the exams for complaints including coughs, headaches and knee accusers said they did not recall him wearing gloves, offering a chaperone or giving "proper explanations" for the examinations before they took at Canterbury Crown Court on Monday, Dr Manson, of Tower Way, Canterbury, denied 18 offences of sexual assault and six of indecent assault. The court heard that Dr Manson worked as a GP between 1994 and 2017, along with working as a GP trainer and programme director of GP training, and as a GP appraiser for the General Medical first complaint of sexual assault against him was filed to Canterbury Police in 2017, followed by an NHS England exercise which saw more alleged victims come a police interview, he said he had never touched a patient for improper or sexual purposes and said every examination was conducted for justified medical reasons, the court was Jennifer Knight KC told jurors Manson also failed to document in patients' notes any potential findings or the the fact such examinations had taken place at all. The first two alleged victims were brothers and both saw Manson before and after they were 16, the court said they were told to pull down their trousers and boxer shorts during a number of Knight said that the elder brother initially "assumed" this was necessary but had gradually become "uncomfortable".Their mother told investigators she never met Dr Manson when her sons were young teenagers as she would always stay in the waiting room, the court heard. Another alleged victim saw Dr Manson twice in 1999 when he was 35 and then 12 years later in 2011, each time with abdominal all three occasions, a genital examination was undertaken and, on both occasions in 1999, his underwear was removed without consent, the court Manson told police this had been necessary to check lymph nodes and femoral pulses in the victim's groin area. However, Ian Wall, a forensic medicine professor and GP, noted there would be no reason to do this, especially without trial continues.
Daily Mail
42 minutes ago
- Daily Mail
Why living until you're 200 really isn't a pipe dream
The idea of living for hundreds of years was once thought to be the pipe dream of billionaires and tech moguls. But scientists at the forefront of anti-ageing research believe they are on the cusp of developing a pill that could lead to people living to the age of 200 and beyond. Medical advances in the last century have led to humans in wealthy nations living into their 80s, almost double the average life expectancy at the turn of the 20th century. Improved nutrition, clean water, better sanitation and huge leaps in medicine have been key in prolonging human life. The oldest known person — the Frenchwoman Jeanne Calment, who sold canvases to Vincent Van Gogh when she was a girl in the late 1800s — lived to the age of 122, dying in 1997. There is some debate about whether humans can naturally live much beyond that age, but it is hoped that science will take human lifespans beyond what is currently thought possible. Dr Andrew Steele, a British computational biologist and author of a new book on longevity, told MailOnline there is no biological reason humans can't reach the age of 200. He believes the big breakthrough will come in the form of drugs that remove 'zombie cells' in the body, which are thought to be one of the main culprits of tissue and organ decay as we age. Pills that flush these cells out of the body are already in human trials in and could be on the market in as little as 10 years, according to Dr Steele, who believes someone reading this could make it to 150 with the help of the drugs. Another field in particular that piques the interest of anti-ageing scientists is the study of DNA of reptiles and other cold-blooded animals. Michigan State University experts have begun studying dozens different types of long-living reptiles and amphibians — including crocodiles, salamanders and turtles that can live as long as 120 years. The team hope they will uncover 'traits' that can also be targeted in humans. Some experts think that eradicating the big killers — cancer, dementia and heart disease — could be the true key to longevity. Dr Steele, the author of Ageless: The New Science of Getting Older Without Getting Old, told MailOnline: 'I don't think there is any kind of absolute cap on how long we can live. 'Studies come out every few years that propose some kind of fundamental limit on human lifespan, but they're always missing one crucial piece: we've never tried treating the ageing process before. 'I can't see physical or biological reason why people couldn't live to 200 — the challenge is whether we've can develop the biomedical science to make it possible.' Other experts believe humans could live to 150 naturally, if it wasn't for chronic illnesses, including Dr Peter Fedichev, a Russian molecular physicist who runs a biomedical AI firm Gero. His company has been studying the genetic data of 500,000 Britons in pursuit of the firm's goal of 'hacking ageing', as they call it. Researchers at Gero made use of an instrument, called DOSI (dynamic organism state indicator), that takes into account age, illness and lifestyle factors, to work out how resilient the body is, including its ability to recover from injury or disease. Using mathematical models, it calculated the maximum age the body — if not altered by drugs or gene therapy — can still recover from is between 120 and 150. The findings were revealed in a study published in the journal Nature Communications last year. But Dr Fedichev warned life extension without improving life quality would be pointless because extremely elderly people would be frail, and prone to illness, meaning new drugs will be vital in the quest for eternal youth. He told MailOnline: 'Such life extension would increase their lifespan past the end of their health span and thus reduce their quality of life. 'Only addressing the root causes of ageing may help bring humans closer to negligibly senescent animals, intercept aging and increase our productive lifespan by a hundred years or more. 'That is why we are calling on a refocusing of our attention from diseases to ageing, from incremental to more radical solutions using those slow-aging animals as inspiration.' Dr Steele says new advances in senolytics could extend life span and quality. Senescent cells — dubbed 'zombie cells' — are cells that eventually stop dividing, then accumulate, releasing compounds in the body that accelerate ageing. Experts believe younger people with healthy immune systems are better able to clear the damaged cells, but as people age, they aren't removed as effectively and they accumulate causing potential problems. Dr Steele said if you put a human cell in a petri dish, it would divide around 50 times before stopping, whereas a Galapagos tortoise — which can live for up to 120 years — sees its cells divide more than 100 times. Studying these sorts of long-living reptiles can help researchers understand more about the way human cells age. Since the 1960s, scientists have known that, as we age, we accumulate ever-greater numbers of these cells, but it wasn't clear if they were just a product of ageing or whether they caused it. The breakthrough came in 2016 when scientists found removing the cells from mice, typically with a short lifespan and plagued with a range of age-related conditions, by injecting them with a synthetic drug called AP20187 extended their life by up to 35 per cent — suggesting senescence was behind ageing itself. Since then, there have been a number of studies confirming the importance of such cells in the ageing process. In 2019, research in the journal Aging Cell showed that old mice pre-treated with Navitoclax, an experimental anti-cancer drug that kills senescent cells, recovered at similar rates to younger mice from an induced heart attack, raising the prospect of a new type of treatment for people with heart conditions. Another study, published in the journal EMBO, demonstrated that clearing out senescent cells from the hearts of mice also reduced symptoms of ageing, such as enlargement and thickening of the walls of the heart muscles. Senolytic drugs are now being safety tested in humans and have attracted investment from several billionaires, including Amazon founder Jeff Bezos and PayPal co-founder Peter Thiel. Dr Steele said: 'Scientists have given these drugs to mice, and they basically get biologically younger: they live longer, get less cancer and heart disease, are less frail — they can run further and faster on the tiny mouse-sized treadmills used in these experiments — and, honestly, they just look great, with plumper skin and thicker fur. 'What this shows us is that tackling the hallmarks of ageing can affect the whole ageing process, from disease risk to the cosmetic stuff, and can do so preventatively — this is the holy grail of anti-ageing medicine.' Both Bezos and Thiel are investors in Unity Biotechnology, which carried out the first human trial of one such drug, aimed at tackling moderate-to-severe osteoarthritis of the knee, in 2019. In the phase one trial, 78 patients were divided into two groups: one was given a dummy drug, while the other was injected in the knee with a drug codenamed UBX0101, which interferes with two proteins in the body, leading to the elimination of senescent cells. The study was a success, with UBX0101 'well-tolerated' by the treated patients, who, after a single injection, had experienced 'improvement in several clinical outcomes, including pain and function'. However, the company faced a setback in 2020 when results from the bigger phase 2 trial found no statistically significant difference between UBX0101 and the placebo groups. Now, the company is trialling a new drug called UBX1325, which has been designed to combat age-related blindness on 46 adults. Dr Steele said it only took one trial to be a success to make a breakthrough in the field of anti-ageing. He told MailOnline: 'We might get unlucky and none of this works but, if it does, every development gives us longer to make the next one, and the first 150-year-old could be someone who's reading this.' Last week, Michigan State University researchers announced they are studying 77 reptiles and amphibians with the hope of understanding what allows them to be so resilient. But they have yet to pinpoint any potential longevity targets, meaning a true breakthrough could still be years off. Dr Alex Zhavoronkov, a biotechnology expert and physicist, said studying animals — particularly those as distantly related to humans as reptiles — has rarely resulted in breakthroughs. He believes scientists are better placed focusing their efforts on studying ageing in real people, and, in particular, technology. Implant chips that use electrodes in the brain to ward off illnesses like Parkinson's are currently being trialled on people. Southmead Hospital in Bristol is believed to be the first in the world to implant the tiny deep brain stimulation (DBS) device when it launched its trial in April. The device works by delivering electrical impulses to damaged areas of the brain. Dr Zhavoronkov said: 'Many years from now humans will be able to control the biology of aging and many other converging technologies will not only return the lost functions but likely augment our capabilities — as you have seen with the glasses, cars, cell phones, the internet, and robotics. 'Advanced technologies starting from dual-purpose pharmaceuticals — drugs that target fundamental aging pathways and age-associated diseases and are trackable with aging biomarkers, which my team is focusing on— to cell and gene therapy and advances in regenerative medicine, implantables, and augmentation of human function with AI and robotics will allow us to dramatically increase life.
Daily Mail
42 minutes ago
- Daily Mail
Forget the ‘vegan hippie' stereotype! People who follow plant-based diets are more POWER-HUNGRY than meat-eaters, study find
You might think that vegetarians and vegans are a bunch of peace-loving hippies. But a new study shows that the stereotype of the tofu-eating pacifist couldn't be further from the truth. Contrary to popular belief, vegetarians actually have a greater hunger for power than their omnivorous peers. Meat-eaters, meanwhile, are more strongly associated with values like kindness, conformity, and social harmony. Study author Dr John Nezlek, of SWPS University in Warsaw, says this mistaken impression likely emerges from the fact that the overwhelming majority of vegetarians are women. However, in reality, vegetarians are much more likely to express traditionally masculine values, such as the desire for personal success, than 'manly' meat-eaters. Dr Nezlek told MailOnline: 'When you think about a vegetarian, you think of someone who's warm, fuzzy, and 'huggy'. 'Well, in terms of the values that people espouse and what they aspire to, it's just not the case.' Dr Nezlek surveyed 3,792 vegetarians, including vegans and those on plant-based diets, and non-vegetarians from the US and Poland. Unlike previous studies which focused on vegetarians' personality traits, Dr Nezlek surveyed the participants to study their deepest convictions and values. During the study participants were given short descriptions of hypothetical individuals such as 'he likes to impress other people' or 'thinking up new ideas and being creative is important to her'. For each of these descriptions, the participant was then asked: 'Do you see yourself in that person?' - responding on a scale from one, not at all, to six, very much like me. These tests are designed to reveal the set of basic values that influence people's patterns of behaviour throughout their lives and determine many of their choices. But when the data came back, the results were so far removed from the established stereotypes that Dr Nezlek initially thought something had gone wrong with the test. However, after collecting more samples, the results clearly showed that everything most people think about vegetarians is incorrect. Contrary to popular belief, vegetarians were consistently more likely to align themselves with values linked to power, defined as the desire for control over people and resources. Vegetarians were also more likely to value personal success or achievement and stimulation in the form of excitement, novelty, or challenges. Omnivores, on the other hand, were more likely to value conformity to social norms, safety and security, and preserving the welfare of those around them. Vegetarians still value 'benevolence', preserving or enhancing the welfare of those close to themselves, but not as much as meat eaters. These differences are not so large that they would be noticeable in one individual - what psychologists would call a 'small to moderate' difference. However, across a large enough population the difference between vegetarians and non-vegetarians would become apparent. Dr Nezlek says: 'Over time, small differences begin to have large consequences and, if you interact with vegetarians over and over again, you begin to see that these people are not tree huggers who are going to back down.' What is less clear is whether having these values predisposes someone towards becoming a vegetarian or if they are developed as a result of the lifestyle change. However, Dr Nezlek says that upcoming research on how long people have remained vegetarian may be able to shed light on this question in the future. Vegetarians also gave less emphasis to values such as conformity, security, and benevolence which are linked with order and tradition. This suggests that the biggest difference between veggies and meat-eaters may be a desire for independence and a non-conformist streak. Yet it also points to a sort of psychological toughness and willingness to go against the grain which is required to be a vegetarian - a group which has historically been a 'berated minority'. Dr Nezlek says: 'If you're a member of a minority group which gets criticized more often than members of the majority, you've got to have some stones to hold those values. 'Particularly because vegetarians adopt their diets, that means they're going to have to stand up for themselves and you've got to have the values that support that.' WHAT SHOULD A BALANCED DIET LOOK LIKE? • Eat at least 5 portions of a variety of fruit and vegetables every day. All fresh, frozen, dried and canned fruit and vegetables count • Base meals on potatoes, bread, rice, pasta or other starchy carbohydrates, ideally wholegrain • 30 grams of fibre a day: This is the same as eating all of the following: 5 portions of fruit and vegetables, 2 whole-wheat cereal biscuits, 2 thick slices of wholemeal bread and large baked potato with the skin on • Have some dairy or dairy alternatives (such as soya drinks) choosing lower fat and lower sugar options • Eat some beans, pulses, fish, eggs, meat and other proteins (including 2 portions of fish every week, one of which should be oily) • Choose unsaturated oils and spreads and consuming in small amounts • Drink 6-8 cups/glasses of water a day
